Literature DB >> 16250680

Increasing constructive anger verbal behavior decreases resting blood pressure: a secondary analysis of a randomized controlled hostility intervention.

K Davidson1, M W Macgregor, J Stuhr, Y Gidron.   

Abstract

We hypothesized that increasing anger verbal behavior in an assertive, constructively motivated style should decrease resting blood pressure (BP) and that this behavior may be one mechanism through which hostility relates to BP. We tested this hypothesis by conducting secondary analyses on a single-blind, matched, randomized controlled study of hostility modification and BP. A total of 22 high-hostile male patients with coronary heart disease were matched on age and hostility level and were randomly assigned to either an 8-week cognitive-behavioral hostility treatment (n = 10) or an information-control group (n = 12). Patients were reassessed after treatment and at 2-month follow-up on hostility, observed anger expression, and resting BP. We found that decreases in hostility predicted increases in constructive anger behavior-verbal component, which in turn predicted decreases in resting BP at follow-up. Thus, one of the mechanisms underlying the hostility-BP association may be the lack of constructive anger expression.

Entities:  

Year:  1999        PMID: 16250680     DOI: 10.1207/s15327558ijbm0603_5

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  21 in total

1.  The control group dilemma in clinical research: applications for psychosocial and behavioral medicine trials.

Authors:  C E Schwartz; M A Chesney; M J Irvine; F J Keefe
Journal:  Psychosom Med       Date:  1997 Jul-Aug       Impact factor: 4.312

2.  Coronary prone behavior: components of the type A pattern and hostility.

Authors:  T M Dembroski; P T Costa
Journal:  J Pers       Date:  1987-06

Review 3.  The functions and regulation of the arousal of anger.

Authors:  R W Novaco
Journal:  Am J Psychiatry       Date:  1976-10       Impact factor: 18.112

4.  The role of anger and hostility in essential hypertension and coronary heart disease.

Authors:  E L Diamond
Journal:  Psychol Bull       Date:  1982-09       Impact factor: 17.737

5.  The short-term effects of a hostility-reduction intervention on male coronary heart disease patients.

Authors:  Y Gidron; K Davidson; I Bata
Journal:  Health Psychol       Date:  1999-07       Impact factor: 4.267

6.  Measures of neuroticism and disease status in coronary angiography patients.

Authors:  J C Barefoot; J C Beckham; B L Peterson; T L Haney; R B Williams
Journal:  J Consult Clin Psychol       Date:  1992-02

7.  Anger and impatience/irritability in patients of low socioeconomic status with acute coronary heart disease.

Authors:  C F Mendes de Leon
Journal:  J Behav Med       Date:  1992-06

8.  Hostility and myocardial ischemia in coronary artery disease patients: evaluation by gender and ischemic index.

Authors:  K F Helmers; D S Krantz; R H Howell; J Klein; C N Bairey; A Rozanski
Journal:  Psychosom Med       Date:  1993 Jan-Feb       Impact factor: 4.312

9.  Cynical hostility, anger, and resting blood pressure.

Authors:  J Spicer; K Chamberlain
Journal:  J Psychosom Res       Date:  1996-04       Impact factor: 3.006

10.  Relationship of trait anger to resting blood pressure: a meta-analysis.

Authors:  J Suls; C K Wan; P T Costa
Journal:  Health Psychol       Date:  1995-09       Impact factor: 4.267

View more
  2 in total

1.  Anger expression and risk of coronary heart disease: evidence from the Nova Scotia Health Survey.

Authors:  Karina W Davidson; Elizabeth Mostofsky
Journal:  Am Heart J       Date:  2010-02       Impact factor: 4.749

2.  "Disruptive behavior" in the operating room: A prospective observational study of triggers and effects of tense communication episodes in surgical teams.

Authors:  Sandra Keller; Franziska Tschan; Norbert K Semmer; Eliane Timm-Holzer; Jasmin Zimmermann; Daniel Candinas; Nicolas Demartines; Martin Hübner; Guido Beldi
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.